AzTrials
AzTrials

Hypothetical Cannabis PurchaseNCT06848543

The Impact of Excise Tax Structures for Retail Marijuana on Marijuana Consumption

A study testing Arm 1 Intervention, Arm 2 Intervention and Arm 3 intervention in people with Hypothetical Cannabis Purchase, run by Ohio State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators will follow probability-based cohorts of adult non-medical marijuana users (N=1,500; ages 21+) and susceptible adolescents and young adults (AYA) users (N=1,000; ages 15-20) over four years. Read more about this study

Who is it for?
Ages 15 years and older
Conditions the study is for
Hypothetical Cannabis Purchase
What is being tested?
Arm 1 Intervention, Arm 2 Intervention and Arm 3 intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
4,696 participants
Where
1 siteUnited States
Study dates
17 Jun 2024to 10 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Adults:
  • aged 21 years and older
  • must be past-30-day dual users of recreational marijuana Adolescents and young adults
  • ages 15-20
  • susceptible to marijuana use

Who cannot join

  • adults older than 21 years who are not using marijuana for recreational purposes
  • youth under age 15
  • teens and young adults who are not susceptible to marijuana use

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Center for Tobacco Research OSU

    Columbus, Ohio, 43214

Other trials in United States

About this study

The investigators will follow probability-based cohorts of adult non-medical marijuana users (N=1,500; ages 21+) and susceptible adolescents and young adults (AYA) users (N=1,000; ages 15-20) over four years. The investigators will use a prospective survey to collect marijuana use information and will conduct volumetric choice experiments (VCEs) where participants choose quantities to purchase among three legal product prototypes: flower, edible, and concentrate; and one illegal flower product, under simulated retail marijuana tax structures. The presentation of edibles and concentrates will change over time to capture the range of product varieties in the market and to accommodate new products and characteristics as they evolve. Choice experiments including VCEs use a series of manipulations as a measurement device to elicit preferences for products and consumption. Therefore, the experimental design is within-subjects with repeated measures, which allow for causal identifications of the impact of design attributes (e.g., tax bases and rates) on preference and consumption outcomes. The attributes and levels are selected to reflect THC levels in the market, existing (weight, price, tiered price by forms) and novel (potency) tax bases, existing (10%-40% of retail price or equivalent in other bases) and potential (high 60% and 80% of retail prices or equivalent) tax rates, and price distribution for each product. Price distribution levels (5 to 95 percentiles) will come from our price data collection and will be updated over time and vary by participants' state and locality of residence.

Before the experiment, study personnel will instruct participants 1) how to answer the choice experiment question, including considering their weekly expenditures when answering VCE questions; 2) that there is no access to other products, no stockpiling, no selling or giving away products to others, etc., to ensure that participants choose products that reflect their usual purchase patterns for self-use; 3) that there are no right or wrong responses. Study personnel will instruct participants to answer all questions honestly, thoughtfully, and to the best of their understanding as if they were actually in this situation, to reduce hypothetical bias; 4) that there may be potential costs or issues associated with purchasing illegal products, including risks of penalties, undefined potency, possible contamination, and inconsistent product quality; and 5) that participants should keep their weekly budget in mind when making purchase choices of the products. In VCEs, the investigators will manipulate THC levels, tax rates and bases, and price levels. Participants will be asked to answer the following: "Imagine these are the marijuana products that you (participants) can purchase for non-medical use, how many of each product would you (participants) most likely buy next time?" Participants can choose more than one product, and as they choose quantities, the total balance will be displayed. To make the tasks easier, study personnel will 1) set a warning to inform participants if their reported budget exceeds their weekly budget for spending; 2) provide a dropdown list for quantities or, if they would like more units than the listed, they can fill in a number; and 3) all products are described as high-quality to allow for a comparison of prices. Half of the participants will be randomized to see itemized pre-tax tag price, excise taxes, and sales taxes, as requested in some states (e.g., Illinois); the other half will be randomized to see only prices that are inclusive of excise taxes. This will allow us to whether excise taxes are more effective when applied at checkout compared to hidden in the tag prices.

Being tested
Arm 1 Intervention, Arm 2 Intervention, Arm 3 intervention

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Arm 1 InterventionBehavioural

    Arm 1 intervention is weight based taxes on cannabis, where participants make hypothetical purchases under weight based taxes.

  • Arm 2 InterventionBehavioural

    Arm 2 intervention is price based taxes on cannabis, where participants make hypothetical purchases under price based taxes.

  • Arm 3 interventionBehavioural

    Arm 3 intervention is potency based taxes on cannabis, where participants make hypothetical purchases under potency based taxes.

Study groups in NCT06848543
Study groupRoleWhat they receive
Tax structure arm 1OtherParticipants are randomized into seeing WEIGHT based taxes for recreational cannabis, then they make hypothetical purchases in responses to products with different THC levels, prices, and taxes.
Receives: Behavioral: Arm 1 Intervention
Tax structure arm 2OtherParticipants are randomized into seeing PRICE based taxes for recreational cannabis, then they make hypothetical purchases in responses to products with different THC levels, prices, and taxes.
Receives: Behavioral: Arm 2 Intervention
Tax structure arm 3OtherParticipants are randomized into seeing potency based taxes for recreational cannabis, then they make hypothetical purchases in responses to products with different THC levels, prices, and taxes.
Receives: Behavioral: Arm 3 intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hypothetical purchase decisions (Unit purchased)

    Number of units that participants intend to purchase, if taxes and prices are set at a certain level.

    Measured: Measures will be collected at baseline, 6 month follow up, 12 month follow up, and the 18 month follow up.

Secondary outcomes (1)
  1. Whether to make a hypothetical purchase

    Dichotomous variable: 0= not purchasing; and 1= purchasing

    Measured: Measures will be collected at baseline, 6 month follow up, 12 month follow up, and the 18 month follow up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2025
  2. Study start17 Jun 2024
  3. Primary completion10 Apr 2026
  4. Study completion10 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Design method: An orthogonal experimental design that identifies the effects of main attributes (4 THC levels, 3 excise tax bases, 5 tax rate levels, 5 pre-tax tag price levels) will result in 300 (3×4×52) choice scenarios. The investigators will use the Ngene software and a D-optimal design to select a subset of all choice scenarios that significantly reduce the total number of choice sets while remaining efficient for model identification. To reduce fatigue, the investigators will develop 2 blocks each containing 12 choice sets, and participants will be randomly assigned to one of these blocks. The order of the 12 choice sets will also be randomized. Before the experiment, participants will be instructed that their answers will be used for research to advance public health and that they should answer truthfully.
Masking
None (open label)
Enrolment
4,696 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06848543
Sponsor's protocol ID
osu-2022B0032
Other IDs
R01DA053294
Status last verified
Apr 2026
First submitted
14 Feb 2025
Last updated
11 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Arm 1 Intervention, Arm 2 Intervention and Arm 3 intervention in people with Hypothetical Cannabis Purchase, run by Ohio State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hypothetical purchase decisions (Unit purchased) (time frame: Measures will be collected at baseline, 6 month follow up, 12 month follow up, and the 18 month follow up.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in